Ryan W. Huey, MD, MS

Ryan W. Huey, MD, MS, is an Associate Professor at The University of Texas MD Anderson Cancer Center. His research focuses on gastrointestinal oncology, specifically colorectal cancer, with an emphasis on minimal residual disease (MRD) detection via circulating tumor DNA (ctDNA), novel immunotherapeutic strategies, and molecular biomarkers such as PI3K mutations. He leads clinical trials investigating TROP2 CAR-engineered NK cells, neoantigen vaccines, and targeted combinations for pancreatic and colorectal cancers. His recent work also explores brain metastases predictors and taxane-based therapies for small bowel adenocarcinoma. Dr. Huey has published extensively in the Journal of Clinical Oncology and The Oncologist, advancing precision oncology and treatment paradigms for high-risk gastrointestinal malignancies.